Company Filing History:
Years Active: 2019-2025
Title: The Innovative Contributions of Dong Liu
Introduction
Dong Liu is a prominent inventor based in Irvine, CA (US). He has made significant contributions to the field of nanoparticle technology, particularly in the development of compositions and methods for nucleic acid active agents. With a total of 3 patents to his name, Liu's work is paving the way for advancements in drug delivery systems.
Latest Patents
Liu's latest patents focus on compositions and methods for creating solid lyophiles of nucleic acid active agents. These compositions can be reconstituted as drug products, which include an aqueous suspension of lipid nanoparticles in a pharmaceutically acceptable solution. The lipid nanoparticles encapsulate one or more nucleic acid active agents, a dextrin compound, and a saccharide compound. Notably, the nucleic acid active agents can be RNAi molecules capable of mediating RNA interference, as well as other RNAs and oligonucleotides.
Career Highlights
Dong Liu is currently employed at Nitto Denko Corporation, where he continues to innovate and develop new technologies. His work has garnered attention for its potential applications in pharmaceuticals and biotechnology. Liu's expertise in nanoparticle technology positions him as a key player in the industry.
Collaborations
Liu collaborates with talented coworkers, including Yuwei Wang and Haiqing Yin. Their combined efforts contribute to the advancement of their projects and the overall success of their research initiatives.
Conclusion
Dong Liu's innovative work in the field of nanoparticle technology and his contributions to drug delivery systems highlight his importance as an inventor. His patents reflect a commitment to advancing medical science and improving therapeutic options.